Navigation Links
Sundia Receives 2011 Zero2IPO Venture 50 Award
Date:11/21/2011

SHANGHAI, Nov. 21, 2011 /PRNewswire-Asia/ -- Sundia MediTech Company Inc., a leading pharmaceutical Contract Research Organization (CRO) in China, announced that the company was named one of the 50 best companies for investment in China in 2011 by Zero2IPO. The news was announced at an October ceremony in Shanghai. This is the third time for Sundia to get this prestigious award after it was previously named in 2007 and 2008.

Zero2IPO-Venture 50 was launched by Zero2IPO Group in 2006. Until now it has become the highest level of enterprise appraisal by venture capitalists in China, and reflects the enterprise with the most potential. The 50 enterprises with the most investment value were selected from a pool of thousands of nominated companies in leading industries by evaluating nominees' business on management team, ownership structure, business model, competitiveness, industry and market, financial situation and forecast, management risks and strategy.

Sundia was founded in 2004 in Shanghai by a group of biotech and pharmaceutical industry veterans from North America. The company has provided integrated R&D outsourcing services to biotech and pharmaceutical clients worldwide. Over the past 7 years, Sundia has successfully established collaborations with over 100 clients in North America, Europe, Japan, Korea and China. Now, Sundia has become a top CRO company in China with 700 employees with operations in Shanghai and Shijiazhuang, the capital city of Hebei Province in Northern China.

Dr. Xiaochuan Wang, Chairman of Sundia attended the ceremony and made a reception speech. "We really appreciate the venture investor for voting Sundia into Venture 50 again. It is recognition of the effort of all of our team members," she acknowledged.


'/>"/>
SOURCE Sundia MediTech Company Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
2. Vascular Designs, Inc. Receives CE Mark Approval for Its IsoFlow™ Infusion Catheter to Target Cancerous Tumors
3. Qualitest Pharmaceuticals Receives FDA Approval for Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL
4. First Patient Receives FDA-Approved Telescope Implant for End-Stage Macular Degeneration
5. Ethicon Endo-Surgery Receives 510(k) Clearance for New ENSEAL® G2 Curved and Straight Tissue Sealers Line -- Broadest Range of Advanced Bipolar Tissue Sealers Available for Open and Minimally Invasive Surgery
6. Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System
7. IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System
8. Augurix Diagnostics Receives the 2011 Debiopharm /Valais Award for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease
9. The Childrens Hospital of Philadelphia Receives Grand Challenges Explorations Funding
10. Femasys Receives FDA 510(k) Clearance for First Low Pressure HSG Device
11. PTC Therapeutics Receives Grand Challenges Explorations Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
(Date:6/8/2017)... ANGELES , June 8, 2017   Responding to ... drug oversight and the death of singer Chris Cornell ... on Human Rights International offers a free online ... better educate consumers and families about psychotropic drug risks. ... Ledger , who died from an accidental overdose, has called ...
Breaking Medicine Technology:
(Date:6/25/2017)... , ... June 25, 2017 , ... Republicans in the ... and replace Obamacare, called the Better Care Reconciliation Act. It differs significantly from the ... will need to be reconciled in committee, or the House will have to take ...
(Date:6/25/2017)... ... ... Men’s Health Month and the focus is on prostate cancer. Second only to ... the third most common cause of cancer related death today; lung cancer remains in the ... with prostate cancer during his lifetime. Those at highest risk are men who ...
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating ... outdoors. Home and business owners should be aware that the summer months provide more ... fact, mechanical locks and keys can be negatively affected from direct exposure to the ...
(Date:6/23/2017)... , ... June 23, 2017 , ... By scoring 100% ... ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ANRF's work ... 1% of all charities reviewed by Charity Navigator and earns ANRF a spot on ...
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. Ran Y. ... has recently begun offering three new minimally invasive procedures to patients who want ... reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, and platelet ...
Breaking Medicine News(10 mins):